Overview

A Confirmatory Study of KUC-7483 in Patients With Overactive Bladder

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and the safety of KUC-7483 in overactive bladder patients.
Phase:
Phase 3
Details
Lead Sponsor:
Kissei Pharmaceutical Co., Ltd.
Treatments:
p-Hydroxyamphetamine
Tolterodine Tartrate